1/10
07:02 pm
exas
Is Exact Sciences (EXAS) Still Attractive After An 81% One Year Share Price Surge [Yahoo! Finance]
Low
Report
Is Exact Sciences (EXAS) Still Attractive After An 81% One Year Share Price Surge [Yahoo! Finance]
1/9
02:11 pm
exas
Halper Sadeh LLC Encourages EXAS, FRGE, TBHC, FFWM Shareholders to Contact the Firm to Discuss Their Rights
Low
Report
Halper Sadeh LLC Encourages EXAS, FRGE, TBHC, FFWM Shareholders to Contact the Firm to Discuss Their Rights
1/9
09:07 am
exas
Biotech Could Be One of 2026's Biggest Winners, and This ETF Is Perfectly Positioned [Yahoo! Finance]
Low
Report
Biotech Could Be One of 2026's Biggest Winners, and This ETF Is Perfectly Positioned [Yahoo! Finance]
1/8
12:48 pm
exas
Halper Sadeh LLC Encourages FRGE, EXAS, CIVI, KVUE Shareholders to Contact the Firm to Discuss Their Rights
Low
Report
Halper Sadeh LLC Encourages FRGE, EXAS, CIVI, KVUE Shareholders to Contact the Firm to Discuss Their Rights
1/7
05:40 pm
exas
Exact Sciences: Abbott Acquisition A Positive Sign For Oncology Diagnostics [Seeking Alpha]
Low
Report
Exact Sciences: Abbott Acquisition A Positive Sign For Oncology Diagnostics [Seeking Alpha]
1/6
07:25 am
exas
Exact Sciences (NASDAQ:EXAS) was downgraded by analysts at Evercore ISI from a "strong-buy" rating to a "hold" rating.
Low
Report
Exact Sciences (NASDAQ:EXAS) was downgraded by analysts at Evercore ISI from a "strong-buy" rating to a "hold" rating.
1/5
08:42 am
exas
Exact Sciences (NASDAQ:EXAS) was given a new $105.00 price target on by analysts at Evercore ISI.
Low
Report
Exact Sciences (NASDAQ:EXAS) was given a new $105.00 price target on by analysts at Evercore ISI.
1/3
05:42 am
exas
Exact Sciences (NASDAQ:EXAS) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Low
Report
Exact Sciences (NASDAQ:EXAS) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
1/1
08:15 am
exas
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now? [Yahoo! Finance]
Low
Report
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now? [Yahoo! Finance]
12/31
11:13 am
exas
3 Unpopular Stocks We Steer Clear Of [Yahoo! Finance]
Low
Report
3 Unpopular Stocks We Steer Clear Of [Yahoo! Finance]
12/31
07:25 am
exas
Smart Oncology: 5 Stocks Chasing the $317B Prize
Low
Report
Smart Oncology: 5 Stocks Chasing the $317B Prize
12/30
09:31 am
exas
Exact Sciences Shareholders Unhappy With $105 Per Share Sale to Abbott Should Contact Julie & Holleman LLP Regarding Potential Claims
Low
Report
Exact Sciences Shareholders Unhappy With $105 Per Share Sale to Abbott Should Contact Julie & Holleman LLP Regarding Potential Claims
12/30
09:07 am
exas
Should You Continue to Hold EXAS Stock in Your Portfolio Now? [Yahoo! Finance]
Low
Report
Should You Continue to Hold EXAS Stock in Your Portfolio Now? [Yahoo! Finance]
12/25
07:00 pm
exas
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? [Yahoo! Finance]
Low
Report
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? [Yahoo! Finance]
12/12
06:02 am
exas
November $10B+ M&A Deals Set Q4 Up To Outpace Prior Quarter [Seeking Alpha]
Low
Report
November $10B+ M&A Deals Set Q4 Up To Outpace Prior Quarter [Seeking Alpha]
12/11
06:06 pm
exas
Exact Sciences, the NSABP Foundation, and the German Breast Group Present Results for the Oncodetect® MRD Test in Early Triple-Negative Breast Cancer at SABCS [Yahoo! Finance]
Neutral
Report
Exact Sciences, the NSABP Foundation, and the German Breast Group Present Results for the Oncodetect® MRD Test in Early Triple-Negative Breast Cancer at SABCS [Yahoo! Finance]
12/11
05:30 pm
exas
Exact Sciences, the NSABP Foundation, and the German Breast Group Present Results for the Oncodetect® MRD Test in Early Triple-Negative Breast Cancer at SABCS
Low
Report
Exact Sciences, the NSABP Foundation, and the German Breast Group Present Results for the Oncodetect® MRD Test in Early Triple-Negative Breast Cancer at SABCS
12/3
11:06 am
exas
Grail: Downgraded From Speculative Buy To Hold As The Stock Price Appreciated Faster Than Expected [Seeking Alpha]
Low
Report
Grail: Downgraded From Speculative Buy To Hold As The Stock Price Appreciated Faster Than Expected [Seeking Alpha]
11/28
07:01 pm
exas
Exact Sciences (NASDAQ:EXAS) was given a new $105.00 price target on by analysts at Stifel Nicolaus.
Low
Report
Exact Sciences (NASDAQ:EXAS) was given a new $105.00 price target on by analysts at Stifel Nicolaus.
11/28
12:41 pm
exas
Halper Sadeh LLC Encourages SEMR, EXAS, MRSN Shareholders to Contact the Firm to Discuss Their Rights
Low
Report
Halper Sadeh LLC Encourages SEMR, EXAS, MRSN Shareholders to Contact the Firm to Discuss Their Rights
11/27
11:11 pm
exas
HAPPY THANKSGIVING AND INVESTOR ALERT: The M&A Class Action Firm Continues to Investigate the Merger - EXAS, SEE, CDTX, and MRSN
Low
Report
HAPPY THANKSGIVING AND INVESTOR ALERT: The M&A Class Action Firm Continues to Investigate the Merger - EXAS, SEE, CDTX, and MRSN
11/27
06:14 pm
exas
HAPPY THANKSGIVING AND ALERT: The M&A Class Action Firm Continues to Investigate the Merger – EXAS, SEE, CDTX, and MRSN
Low
Report
HAPPY THANKSGIVING AND ALERT: The M&A Class Action Firm Continues to Investigate the Merger – EXAS, SEE, CDTX, and MRSN
11/26
06:43 am
exas
Exact Sciences (NASDAQ:EXAS) was downgraded by analysts at TD Cowen from a "strong-buy" rating to a "hold" rating.
Low
Report
Exact Sciences (NASDAQ:EXAS) was downgraded by analysts at TD Cowen from a "strong-buy" rating to a "hold" rating.
11/25
09:35 am
exas
Here Are Tuesday's Top Wall Street Analyst Research Calls: Applied Materials, CDW, Exact Sciences, Harley-Davidson, Oshkosh, ServiceNow and More [Yahoo! Finance]
Low
Report
Here Are Tuesday's Top Wall Street Analyst Research Calls: Applied Materials, CDW, Exact Sciences, Harley-Davidson, Oshkosh, ServiceNow and More [Yahoo! Finance]
11/25
01:33 am
exas
Halper Sadeh LLC Encourages GDOT, BLFY, EXAS Shareholders to Contact the Firm to Discuss Their Rights
Low
Report
Halper Sadeh LLC Encourages GDOT, BLFY, EXAS Shareholders to Contact the Firm to Discuss Their Rights